Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here
Monday, September 10, 2012
Hepatitis epidemic must be tackled to stop liver cancer cases doubling
A physician with the Victorian Infectious Diseases Service, Benjamin Cowie, said liver cancer cases were expected to double to about 2500 a year if more was not done to tackle the underlying causes. Hepatitis B and C were the primary causes of liver cancer, with hepatitis B the most significant single cause of cancer worldwide, after tobacco, Dr Cowie said.
Hepatitis B affected about 200,000 Australians, most of them Aboriginal or born overseas in countries where there was an epidemic. Hepatitis C affected about 230,000 Australians and was most commonly caused by drug users sharing needles.